<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37559147</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>09</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>HMGB1 is involved in viral replication and the inflammatory response in coxsackievirus A16-infected 16HBE cells via proteomic analysis and identification.</ArticleTitle><Pagination><StartPage>178</StartPage><MedlinePgn>178</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">178</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-023-02150-8</ELocationID><Abstract><AbstractText>Coxsackievirus A16 (CV-A16) is still an important pathogen that causes hand, foot and mouth disease (HFMD) in young children and infants worldwide. Previous studies indicated that CV-A16 infection is usually mild or self-limiting, but it was also found that CV-A16 infection can trigger severe neurological complications and even death. However, there are currently no vaccines or antiviral compounds available to either prevent or treat CV-A16 infection. Therefore, investigation of the virus‒host interaction and identification of host proteins that play a crucial regulatory role in the pathogenesis of CV-A16 infection may provide a novel strategy to develop antiviral drugs. Here, to increase our understanding of the interaction of CV-A16 with the host cell, we analyzed changes in the proteome of 16HBE cells in response to CV-A16 using tandem mass tag (TMT) in combination with LC‒MS/MS. There were 6615 proteins quantified, and 172 proteins showed a significant alteration during CV-A16 infection. These differentially regulated proteins were involved in fundamental biological processes and signaling pathways, including metabolic processes, cytokine‒cytokine receptor interactions, B-cell receptor signaling pathways, and neuroactive ligand‒receptor interactions. Further bioinformatics analysis revealed the characteristics of the protein domains and subcellular localization of these differentially expressed proteins. Then, to validate the proteomics data, 3 randomly selected proteins exhibited consistent changes in protein expression with the TMT results using Western blotting and immunofluorescence methods. Finally, among these differentially regulated proteins, we primarily focused on HMGB1 based on its potential effects on viral replication and virus infection-induced inflammatory responses. It was demonstrated that overexpression of HMGB1 could decrease viral replication and upregulate the release of inflammatory cytokines, but deletion of HMGB1 increased viral replication and downregulated the release of inflammatory cytokines. In conclusion, the results from this study have helped further elucidate the potential molecular pathogenesis of CV-A16 based on numerous protein changes and the functions of HMGB1 Found to be involved in the processes of viral replication and inflammatory response, which may facilitate the development of new antiviral therapies as well as innovative diagnostic methods.</AbstractText><CopyrightInformation>© 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Hu</LastName><ForeName>Yajie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yang</LastName><ForeName>Jinghui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Mingmei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Baojiang</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yunhui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Yunnan Province, Kunming, China. zhangyh123kh@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China. zhangyh123kh@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China. songjiekm@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024243">HMGB1 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002853" MajorTopicYN="N">Chromatography, Liquid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024243" MajorTopicYN="Y">HMGB1 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053719" MajorTopicYN="N">Tandem Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsackievirus A16 (CV-A16)</Keyword><Keyword MajorTopicYN="N">High mobility group box protein 1 (HMGB1)</Keyword><Keyword MajorTopicYN="N">Inflammatory response</Keyword><Keyword MajorTopicYN="N">Tandem mass tag (TMT)-based quantitative proteomics</Keyword><Keyword MajorTopicYN="N">Viral replication</Keyword><Keyword MajorTopicYN="N">Virus‒host interaction</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>10</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37559147</ArticleId><ArticleId IdType="pmc">PMC10410909</ArticleId><ArticleId IdType="doi">10.1186/s12985-023-02150-8</ArticleId><ArticleId IdType="pii">10.1186/s12985-023-02150-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Saguil A, Kane SF, Lauters R, Mercado MG. Hand-foot-and-mouth disease: rapid evidence review. Am Fam Phys. 2019;100:408–414.</Citation><ArticleIdList><ArticleId IdType="pubmed">31573162</ArticleId></ArticleIdList></Reference><Reference><Citation>Aswathyraj S, Arunkumar G, Alidjinou EK, Hober D. Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. Med Microbiol Immunol. 2016;205:397–407. doi: 10.1007/s00430-016-0465-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-016-0465-y</ArticleId><ArticleId IdType="pubmed">27406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Principi N. Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention. Eur J Clin Microbiol Infect Dis. 2018;37:391–398. doi: 10.1007/s10096-018-3206-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-018-3206-x</ArticleId><ArticleId IdType="pubmed">29411190</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YK, Chen KH, Chen KT. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development. Rev Inst Med Trop Sao Paulo. 2018;60:e70. doi: 10.1590/s1678-9946201860070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s1678-9946201860070</ArticleId><ArticleId IdType="pmc">PMC6223252</ArticleId><ArticleId IdType="pubmed">30427405</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein M, Chong P. Is a multivalent hand, foot, and mouth disease vaccine feasible? Hum Vaccin Immunother. 2015;11:2688–2704. doi: 10.1080/21645515.2015.1049780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2015.1049780</ArticleId><ArticleId IdType="pmc">PMC4685682</ArticleId><ArticleId IdType="pubmed">26009802</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao QY, Wang Y, Bian L, Xu M, Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD) Expert Rev Vaccines. 2016;15:599–606. doi: 10.1586/14760584.2016.1138862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1138862</ArticleId><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Wang Y, Yao X, Bian L, Wu X, Xu M, Liang Z. Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother. 2014;10:360–367. doi: 10.4161/hv.27087.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.27087</ArticleId><ArticleId IdType="pmc">PMC4185891</ArticleId><ArticleId IdType="pubmed">24231751</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobbin JC, Charon J, Harvey E, Holmes EC, Mahar JE. Current challenges to virus discovery by meta-transcriptomics. Curr Opin Virol. 2021;51:48–55. doi: 10.1016/j.coviro.2021.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2021.09.007</ArticleId><ArticleId IdType="pubmed">34592710</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, Hu Y, Li W, Li H, Zheng H, Chen Y, Dong S, Liu L. Transcriptome analysis following enterovirus 71 and coxsackievirus A16 infection in respiratory epithelial cells. Arch Virol. 2020;165:2817–2828. doi: 10.1007/s00705-020-04821-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-020-04821-1</ArticleId><ArticleId IdType="pmc">PMC7522011</ArticleId><ArticleId IdType="pubmed">32990841</ArticleId></ArticleIdList></Reference><Reference><Citation>Martianez-Vendrell X, Kikkert M. Proteomics approaches for the identification of protease substrates during virus infection. Adv Virus Res. 2021;109:135–161. doi: 10.1016/bs.aivir.2021.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.aivir.2021.03.003</ArticleId><ArticleId IdType="pubmed">33934826</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann K, Tascher G, Munch C. Virus systems biology: proteomics profiling of dynamic protein networks during infection. Adv Virus Res. 2021;109:1–29. doi: 10.1016/bs.aivir.2020.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.aivir.2020.12.001</ArticleId><ArticleId IdType="pubmed">33934824</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerold G, Bruening J, Pietschmann T. Decoding protein networks during virus entry by quantitative proteomics. Virus Res. 2016;218:25–39. doi: 10.1016/j.virusres.2015.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2015.09.006</ArticleId><ArticleId IdType="pmc">PMC4914609</ArticleId><ArticleId IdType="pubmed">26365680</ArticleId></ArticleIdList></Reference><Reference><Citation>Coombs KM. Update on Proteomic approaches to uncovering virus-induced protein alterations and virus–host protein interactions during the progression of viral infection. Expert Rev Proteom. 2020;17:513–532. doi: 10.1080/14789450.2020.1821656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14789450.2020.1821656</ArticleId><ArticleId IdType="pubmed">32910682</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Z, Yuan C, Han Y, Zhou L, Zhao J, Ruan Y, Chen J, Ni M, Ji X. TMT-based quantitative proteomics analysis reveals the attenuated replication mechanism of Newcastle disease virus caused by nuclear localization signal mutation in viral matrix protein. Virulence. 2020;11:607–635. doi: 10.1080/21505594.2020.1770482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2020.1770482</ArticleId><ArticleId IdType="pmc">PMC7549962</ArticleId><ArticleId IdType="pubmed">32420802</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma KB, Chhabra S, Aggarwal S, Tripathi A, Banerjee A, Yadav AK, Vrati S, Kalia M. Proteomic landscape of Japanese encephalitis virus-infected fibroblasts. J Gen Virol 2021;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">34546869</ArticleId></ArticleIdList></Reference><Reference><Citation>He W, Li C, Dong L, Yang G, Liu H. Tandem mass tag-based quantitative proteomic analysis of ISG15 knockout PK15 cells in pseudorabies virus infection. Genes (Basel) 2021;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8535405</ArticleId><ArticleId IdType="pubmed">34680952</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng X, Chan EY, Li Y, Diamond DL, Korth MJ, Katze MG. Virus-host interactions: from systems biology to translational research. Curr Opin Microbiol. 2009;12:432–438. doi: 10.1016/j.mib.2009.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2009.06.003</ArticleId><ArticleId IdType="pmc">PMC2742299</ArticleId><ArticleId IdType="pubmed">19576841</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Song J, Liu L, Zhang Y, Wang L, Li Q. microRNA-4516 contributes to different functions of epithelial permeability barrier by targeting poliovirus receptor related protein 1 in Enterovirus 71 and Coxsackievirus A16 infections. Front Cell Infect Microbiol. 2018;8:110. doi: 10.3389/fcimb.2018.00110.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2018.00110</ArticleId><ArticleId IdType="pmc">PMC5900049</ArticleId><ArticleId IdType="pubmed">29686973</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Zhang R, Wu W, Duan G. Innate immunity evasion by enteroviruses linked to epidemic hand-foot-mouth disease. Front Microbiol. 2018;9:2422. doi: 10.3389/fmicb.2018.02422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.02422</ArticleId><ArticleId IdType="pmc">PMC6186807</ArticleId><ArticleId IdType="pubmed">30349526</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan X, Liu Z, Wan L, Liu W, Huang Y, Cao S. Recent advances in anti-coxsackievirus A16 viral drug research. Future Med Chem. 2023;15:97–117. doi: 10.4155/fmc-2022-0195.</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/fmc-2022-0195</ArticleId><ArticleId IdType="pubmed">36538291</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X, Li S, Zhu L. Potential effects of HMGB1 on viral replication and virus infection-induced inflammatory responses: a promising therapeutic target for virus infection-induced inflammatory diseases. Cytokine Growth Factor Rev. 2021;62:54–61. doi: 10.1016/j.cytogfr.2021.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.08.003</ArticleId><ArticleId IdType="pubmed">34503914</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Sastre A, Sansonetti PJ. Host-pathogen interactions. Curr Opin Immunol. 2010;22:425–427. doi: 10.1016/j.coi.2010.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2010.06.005</ArticleId><ArticleId IdType="pubmed">20621460</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicod C, Banaei-Esfahani A, Collins BC. Elucidation of host-pathogen protein-protein interactions to uncover mechanisms of host cell rewiring. Curr Opin Microbiol. 2017;39:7–15. doi: 10.1016/j.mib.2017.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2017.07.005</ArticleId><ArticleId IdType="pmc">PMC5732060</ArticleId><ArticleId IdType="pubmed">28806587</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperk M, van Domselaar R, Rodriguez JE, Mikaeloff F, Sa Vinhas B, Saccon E, Sonnerborg A, Singh K, Gupta S, Vegvari A, Neogi U. Utility of proteomics in emerging and re-emerging infectious diseases caused by RNA viruses. J Proteome Res. 2020;19:4259–4274. doi: 10.1021/acs.jproteome.0c00380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00380</ArticleId><ArticleId IdType="pmc">PMC7640957</ArticleId><ArticleId IdType="pubmed">33095583</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Sugrue RJ, Tang K. Mass spectrometry based proteomic studies on viruses and hosts—a review. Anal Chim Acta. 2011;702:149–159. doi: 10.1016/j.aca.2011.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aca.2011.06.045</ArticleId><ArticleId IdType="pmc">PMC7094357</ArticleId><ArticleId IdType="pubmed">21839192</ArticleId></ArticleIdList></Reference><Reference><Citation>Cakir T, Panagiotou G, Uddin R, Durmus S. Novel approaches for systems biology of metabolism-oriented pathogen-human interactions: a mini-review. Front Cell Infect Microbiol. 2020;10:52. doi: 10.3389/fcimb.2020.00052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00052</ArticleId><ArticleId IdType="pmc">PMC7031156</ArticleId><ArticleId IdType="pubmed">32117818</ArticleId></ArticleIdList></Reference><Reference><Citation>Judge A, Dodd MS. Metabolism. Essays Biochem. 2020;64:607–647. doi: 10.1042/EBC20190041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/EBC20190041</ArticleId><ArticleId IdType="pmc">PMC7545035</ArticleId><ArticleId IdType="pubmed">32830223</ArticleId></ArticleIdList></Reference><Reference><Citation>Filomeni G, De Zio D, Cecconi F. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 2015;22:377–388. doi: 10.1038/cdd.2014.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2014.150</ArticleId><ArticleId IdType="pmc">PMC4326572</ArticleId><ArticleId IdType="pubmed">25257172</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur J, Debnath J. Autophagy at the crossroads of catabolism and anabolism. Nat Rev Mol Cell Biol. 2015;16:461–472. doi: 10.1038/nrm4024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm4024</ArticleId><ArticleId IdType="pubmed">26177004</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo D, Gammon DB. Manipulation of the host cytoskeleton by viruses: insights and mechanisms. Viruses 2022;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9323041</ArticleId><ArticleId IdType="pubmed">35891564</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo KY, Chee HY. Interaction between flavivirus and cytoskeleton during virus replication. Biomed Res Int. 2015;2015:427814. doi: 10.1155/2015/427814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/427814</ArticleId><ArticleId IdType="pmc">PMC4546964</ArticleId><ArticleId IdType="pubmed">26347881</ArticleId></ArticleIdList></Reference><Reference><Citation>Leite F, Way M. The role of signalling and the cytoskeleton during Vaccinia Virus egress. Virus Res. 2015;209:87–99. doi: 10.1016/j.virusres.2015.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2015.01.024</ArticleId><ArticleId IdType="pubmed">25681743</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda-Saksena M, Denes CE, Diefenbach RJ, Cunningham AL. Infection and transport of herpes simplex virus type 1 in neurons: role of the cytoskeleton. Viruses 2018;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5850399</ArticleId><ArticleId IdType="pubmed">29473915</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmonds P, Aiewsakun P. Virus classification—Where do you draw the line? Arch Virol. 2018;163:2037–2046. doi: 10.1007/s00705-018-3938-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-018-3938-z</ArticleId><ArticleId IdType="pmc">PMC6096723</ArticleId><ArticleId IdType="pubmed">30039318</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang HD, Neault S, Pelin A, Alain T. Emerging translation strategies during virus-host interaction. Wiley Interdiscip Rev RNA. 2021;12:e1619. doi: 10.1002/wrna.1619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1619</ArticleId><ArticleId IdType="pmc">PMC7435527</ArticleId><ArticleId IdType="pubmed">32757266</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallego J, Varani G. The hepatitis C virus internal ribosome-entry site: a new target for antiviral research. Biochem Soc Trans. 2002;30:140–145. doi: 10.1042/bst0300140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bst0300140</ArticleId><ArticleId IdType="pubmed">12023841</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Pu J, Liu L, Che Y, Liao Y, Wang L, Guo L, Feng M, Liang Y, Fan S, et al. Clinical and associated immunological manifestations of HFMD caused by different viral infections in children. Glob Pediatr Health 2016;3:2333794X16643723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4905128</ArticleId><ArticleId IdType="pubmed">27336013</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Q, Peng W, Chen LI. Coxsackievirus A16 infection stimulates imbalances of T cells in children. Exp Ther Med. 2015;9:2213–2218. doi: 10.3892/etm.2015.2405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2015.2405</ArticleId><ArticleId IdType="pmc">PMC4473379</ArticleId><ArticleId IdType="pubmed">26136962</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Li G. Immune response and blood-brain barrier dysfunction during viral neuroinvasion. Innate Immun. 2021;27:109–117. doi: 10.1177/1753425920954281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753425920954281</ArticleId><ArticleId IdType="pmc">PMC7882805</ArticleId><ArticleId IdType="pubmed">32903111</ArticleId></ArticleIdList></Reference><Reference><Citation>Patro ARK, Mohanty S, Prusty BK, Singh DK, Gaikwad S, Saswat T, Chattopadhyay S, Das BK, Tripathy R, Ravindran B. Cytokine signature associated with disease severity in dengue. Viruses 2019;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6357178</ArticleId><ArticleId IdType="pubmed">30626045</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida RS, Ferreira MLB, Sonon P, Cordeiro MT, Sadissou I, Diniz GTN, Militao-Albuquerque MFP, Franca RFO, Donadi EA, Lucena-Silva N. Cytokines and soluble HLA-g levels in the acute and recovery phases of arbovirus-infected Brazilian patients exhibiting neurological complications. Front Immunol. 2021;12:582935. doi: 10.3389/fimmu.2021.582935.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.582935</ArticleId><ArticleId IdType="pmc">PMC7994272</ArticleId><ArticleId IdType="pubmed">33776990</ArticleId></ArticleIdList></Reference><Reference><Citation>Faizan MI, Abdullah M, Ali S, Naqvi IH, Ahmed A, Parveen S. Zika virus-induced microcephaly and its possible molecular mechanism. Intervirology. 2016;59:152–158. doi: 10.1159/000452950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000452950</ArticleId><ArticleId IdType="pubmed">28081529</ArticleId></ArticleIdList></Reference><Reference><Citation>Lees JG, Dawson NL, Sillitoe I, Orengo CA. Functional innovation from changes in protein domains and their combinations. Curr Opin Struct Biol. 2016;38:44–52. doi: 10.1016/j.sbi.2016.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2016.05.016</ArticleId><ArticleId IdType="pubmed">27309309</ArticleId></ArticleIdList></Reference><Reference><Citation>Hountondji C, Bulygin K, Woisard A, Tuffery P, Crechet JB, Pech M, Nierhaus KH, Karpova G, Baouz S. Lys53 of ribosomal protein L36AL and the CCA end of a tRNA at the P/E hybrid site are in close proximity on the human ribosome. ChemBioChem. 2012;13:1791–1797. doi: 10.1002/cbic.201200208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbic.201200208</ArticleId><ArticleId IdType="pubmed">22865768</ArticleId></ArticleIdList></Reference><Reference><Citation>Du P, Li T, Wang X. Recent progress in predicting protein sub-subcellular locations. Expert Rev Proteom. 2011;8:391–404. doi: 10.1586/epr.11.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/epr.11.20</ArticleId><ArticleId IdType="pubmed">21679119</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Li Z, Zeng T, Zhang YH, Zhang S, Huang T, Cai YD. Predicting human protein subcellular locations by using a combination of network and function features. Front Genet. 2021;12:783128. doi: 10.3389/fgene.2021.783128.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.783128</ArticleId><ArticleId IdType="pmc">PMC8603309</ArticleId><ArticleId IdType="pubmed">34804131</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1:a001651. doi: 10.1101/cshperspect.a001651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a001651</ArticleId><ArticleId IdType="pmc">PMC2882124</ArticleId><ArticleId IdType="pubmed">20457564</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorlich D, Kutay U. Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Dev Biol. 1999;15:607–660. doi: 10.1146/annurev.cellbio.15.1.607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.cellbio.15.1.607</ArticleId><ArticleId IdType="pubmed">10611974</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Ward MF, Sama AE, Wang H. Extracellular HMGB1 as a proinflammatory cytokine. J Interferon Cytokine Res. 2004;24:329–333. doi: 10.1089/107999004323142187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/107999004323142187</ArticleId><ArticleId IdType="pubmed">15212706</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng C, Zhao L, Yang Z, Shang JJ, Wang CY, Shen MZ, Jiang S, Li T, Di WC, Chen Y, et al. Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury. Acta Pharmacol Sin. 2022;43:520–528. doi: 10.1038/s41401-021-00676-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-021-00676-7</ArticleId><ArticleId IdType="pmc">PMC8888646</ArticleId><ArticleId IdType="pubmed">34040166</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudson BI, Lippman ME. Targeting RAGE signaling in inflammatory disease. Annu Rev Med. 2018;69:349–364. doi: 10.1146/annurev-med-041316-085215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-041316-085215</ArticleId><ArticleId IdType="pubmed">29106804</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Ward MF, Fan XG, Sama AE, Li W. Potential role of high mobility group box 1 in viral infectious diseases. Viral Immunol. 2006;19:3–9. doi: 10.1089/vim.2006.19.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2006.19.3</ArticleId><ArticleId IdType="pmc">PMC1782047</ArticleId><ArticleId IdType="pubmed">16553546</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu Y, Zhan Y, Yang S, Ren S, Qiu X, Rehamn ZU, Tan L, Sun Y, Meng C, Song C, et al. Newcastle disease virus infection triggers HMGB1 release to promote the inflammatory response. Virology. 2018;525:19–31. doi: 10.1016/j.virol.2018.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2018.09.001</ArticleId><ArticleId IdType="pubmed">30216776</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary N, Srivastava S, Gupta S, Menon MB, Patel AK. Dengue virus induced autophagy is mediated by HMGB1 and promotes viral propagation. Int J Biol Macromol. 2023;229:624–635. doi: 10.1016/j.ijbiomac.2022.12.299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2022.12.299</ArticleId><ArticleId IdType="pubmed">36587643</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing J, Liang J, Liu S, Huang L, Hu P, Liu L, Liao M, Qi W. Japanese encephalitis virus restricts HMGB1 expression to maintain MAPK pathway activation for viral replication. Vet Microbiol. 2021;262:109237. doi: 10.1016/j.vetmic.2021.109237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2021.109237</ArticleId><ArticleId IdType="pubmed">34592637</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W, Shi H, Chen Y, Xu Z, Chen J, Jin L. Alteration of serum high-mobility group protein 1 (HMGB1) levels in children with enterovirus 71-induced hand, foot, and mouth disease. Medicine (Baltimore) 2017;96:e6764. doi: 10.1097/MD.0000000000006764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000006764</ArticleId><ArticleId IdType="pmc">PMC5413272</ArticleId><ArticleId IdType="pubmed">28445307</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson U, Ottestad W, Tracey KJ. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19? Mol Med. 2020;26:42. doi: 10.1186/s10020-020-00172-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-020-00172-4</ArticleId><ArticleId IdType="pmc">PMC7203545</ArticleId><ArticleId IdType="pubmed">32380958</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>